Reply to Hasford and to Spinola et al
J Infect Dis
.
2020 Oct 1;222(9):1574-1575.
doi: 10.1093/infdis/jiaa458.
Authors
Nir Eyal
1
2
3
,
Marc Lipsitch
4
5
,
Peter G Smith
6
Affiliations
1
Center for Population-Level Bioethics, Rutgers University, New Brunswick, New Jersey, USA.
2
Department of Philosophy, Rutgers University, New Brunswick, New Jersey, USA.
3
Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, New Jersey, USA.
4
Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
5
Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
6
MRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK.
PMID:
32845306
PMCID:
PMC7529012
DOI:
10.1093/infdis/jiaa458
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Comment
MeSH terms
COVID-19 Vaccines*
Coronavirus*
Humans
Licensure
Vaccination
Substances
COVID-19 Vaccines
Grant support
MR/R010161/1/MRC_/Medical Research Council/United Kingdom
R01 AI114617/AI/NIAID NIH HHS/United States
R56 AI114617/AI/NIAID NIH HHS/United States
U54 GM088558/GM/NIGMS NIH HHS/United States